Financial Disclosures - The Canadian Association of Gastroenterology

CDDW 2013 & the Annual CASL Winter MeetingFaculty Financial Interest DisclosureThe Canadian Association of Gastroenterology and the Canadian Association for the Study of the Liver must ensure balance, independence, objectivity, and scientific rigour inall educational and scientific activities. Accordingly, CDDW/CASL Winter Meeting faculty is expected to disclose to the audience any potential, apparent or actual interests orconnections that appear to influence their ability to act with integrity, objectivity, and independence on the assigned task. The intent of this disclosure summary is to providethe audience with information on the faculty interests/relationships that could influence interpretations, recommendations, and conclusions. For more information visit theCAG website at: http://www.cag‐acg.org/policiesThe following faculty have indicated that they do have relevant financial relationships of commercial interestAllard, JohaneArmstrong,DavidBajaj, JasmohanBercik, PremyslBernstein,CharlesBirch, DanielBressler, BrianBrill, HerbertBurak, KellyCoffin, CarlaCroitoru, KenCryan, JohnDevlin, ShaneEnns, RobertFeagan, BrianFedorak, RichardFeld, JordanForget, SylvianeFung, ScottAbbott Nutrition (Company Advisory Board, Consultant); Baxter Healthcare Corporation (Company Advisory Board, Consultant)Aptalis (Other); AbbVie (Speaker’s Bureau, Consultant, Research Support); Shire (Speaker’s Bureau, Company Advisory Board);Janssen (Speaker’s Bureau, Company Advisory Board, Research Support); Takeda (Speaker’s Bureau, Company Advisory Board,Research Support, Consultant); Pendopharm (Speaker’s Bureau, Company Advisory Board); Ferring (Other); Pentax (Speaker’sBureau, Research Support, Other); Olympus (Other); Cook (Other); ConMed (Other); Warner‐Chilcott (Other)Salix Pharmaceuticals, Inc. (Consultant, Research Support); Otsuka America Pharmaceutical Inc. (Research Support)Nestec Swizerland (Research Support); Janssen Canada (Company Advisory Board); Forest Laboratories Canada (Consultant)Abbott Canada (Consultant, Research Support); Janssen Canada (Consultant); Shire Canada (Consultant); Aptalis Pharmaceuticals(Other); Vertex Pharmaceuticals (Consultant); Bristol‐Myers Squibb (Consultant)Johnson & Johnson Health Care Companies (Company Advisory Board, Other); Covidien Formerly Autosuture & Valley (CompanyAdvisory Board); Bard (Consultant); Olympus America, Inc. (Consultant); Stryker Endoscopy (Other)Janssen (Speaker’s Bureau, Company Advisory Board); Abbott (Speaker’s Bureau, Company Advisory Board); Shire U.S. Inc.(Speaker’s Bureau, Company Advisory Board); Ferring Pharmaceuticals Inc (Speaker’s Bureau); Takeda Pharmaceutical CompanyLtd (Research Support); Amgen (Research Support); Bristol‐Myers Squibb (Research Support); GlaxoSmithKline (ResearchSupport); Alba Therapeutics (Research Support); Aptalis (Speaker’s Bureau); Cardiome (Consultant); Qubiologics (Consultant);Merck & Co (Consultant); Centocor, Inc. (Research Support)Ferring Pharmaceuticals Inc (Speaker’s Bureau, Company Advisory Board); Janssen (Company Advisory Board)Bayer Healthcare Pharmaceuticals/Onyx Pharmaceuticals (Research Support); Bristol‐Myers Squibb (Research Support); Pfizer Inc(Research Support); Genentech Inc. (Research Support); Astellas Pharma Inc. (Company Advisory Board, Other); Gilead SciencesInc (Company Advisory Board); Roche (Other); Merck & Co (Other); Vertex Pharmaceuticals (Company Advisory Board)Gilead Sciences Inc (Research Support); BMS (Research Support); Roche (Research Support)Abbott (Other); Janssen (Other); Shire Pharmaceuticals Group Plc (Other)Addex Pharma (Speaker’s Bureau); Mead Johnson Nutritionals (Speaker’s Bureau, Research Support)Janssen (Consultant, Company Advisory Board, Speaker’s Bureau); Abbott (Consultant, Company Advisory Board, Speaker’s Bureau);Shire Pharmaceuticals Group Plc (Consultant, Company Advisory Board, Speaker’s Bureau)Merck & Co (Research Support, Company Advisory Board); Abbott (Research Support, Company Advisory Board); TakedaPharmaceutical Company Ltd (Research Support, Company Advisory Board); Procter & Gamble Pharmaceuticals (ResearchSupport); Olympus America, Inc. (Research Support, Company Advisory Board); PENTAX Medical Company (Research Support);CONMED Endoscopic Technologies (Research Support); AstraZeneca Pharmaceuticals LP (Research Support, Company AdvisoryBoard); Janssen (Research Support, Company Advisory Board); Shire (Research Support, Company Advisory Board); BostonScientific Corporation (Research Support); Cook Endoscopy (Research Support); Aptalis (Research Support)Abbott (Speaker’s Bureau, Consultant); UCB (Speaker’s Bureau, Consultant); J&J (Speaker’s Bureau, Consultant); Merck (Consultant,Company Advisory Board); Takeda (Consultant); Millennium Research Group (Consultant); Tillots Pharma (Consultant, CompanyAdvisory Board); Prometheus Laboratories Inc. (Consultant, Company Advisory Board); Novartis Pharmaceuticals (ResearchSupport); Pfizer Inc (Consultant); Bristol‐Myers Squibb (Research Support, Consultant); Teva Pharmaceutical Industries Ltd.(Consultant); AstraZeneca Pharmaceuticals LP (Consultant, Company Advisory Board); Celgene Corporation (Consultant,Company Advisory Board); Genentech Inc. (Consultant); Nova Nordisk A/S (Consultant); Gilead Sciences Inc (Consultant); GivenImaging (Consultant); Sigmoid Pharma (Consultant); Zyngenia (Consultant); Janssen (Consultant)Abbott (Research Support, Consultant); Janssen (Research Support, Consultant); Ferring Pharmaceuticals Inc (Research Support,Consultant); Millennium Research Group (Research Support); Gilead Sciences Inc (Research Support); Centocor, Inc. (ResearchSupport, Consultant); UCB, Inc. (Research Support); GlaxoSmithKline (Research Support); Merck & Co (Research Support,Consultant); Alba Therapeutics (Research Support); Alvine Inc (Research Support); VSL Inc (Research Support); Bristol‐MyersSquibb (Research Support); Novartis Pharmaceuticals (Research Support); Shire Pharmaceuticals Group Plc (Research Support,Consultant); Genentech Inc. (Research Support); Procter & Gamble Pharmaceuticals (Research Support); MetabolomicTechnologies Inc (Stockholder)Merck & Co (Company Advisory Board, Speaker’s Bureau); Abbott (Company Advisory Board, Speaker’s Bureau); Gilead Sciences Inc(Company Advisory Board); Roche (Company Advisory Board, Speaker’s Bureau); Vertex Pharmaceuticals (Company AdvisoryBoard); Boehringer Ingelheim (Company Advisory Board)Nestle Nutrition (Speaker’s Bureau); Janssen (Company Advisory Board); UCB, Inc. (Consultant)Gilead Sciences Inc (Company Advisory Board, Speaker’s Bureau); Merck & Co (Company Advisory Board, Speaker’s Bureau); Roche(Research Support); Vertex Pharmaceuticals (Company Advisory Board); Bristol‐Myers Squibb (Research Support)

CDDW 2013 & the Annual CASL Winter MeetingFaculty Financial Interest DisclosureThe Canadian Association of Gastroenterology and the Canadian Association for the Study of the Liver must ensure balance, independence, objectivity, and scientific rigour inall educational and scientific activities. Accordingly, CDDW/CASL Winter Meeting faculty is expected to disclose to the audience any potential, apparent or actual interests orconnections that appear to influence their ability to act with integrity, objectivity, and independence on the assigned task. The intent of this disclosure summary is to providethe audience with information on the faculty interests/relationships that could influence interpretations, recommendations, and conclusions. For more information visit theCAG website at: http://www.cag‐acg.org/policiesThe following faculty have indicated that they do have relevant financial relationships of commercial interestGhosh, SubrataGriffiths, AnneHookey, LawrenceHuynh, HienInadomi, JohnIrving, PeterJacobson, KevanJones, JenniferKaplan, GilaadKroeker, KarenLazarescu,AdrianaLee, SamLieberman,DavidLindsay, JamesLiu, LouisMa, MangMarotta, PaulMarshall, JohnMason, AndrewMay, GaryMcKnight, LisaMenne, StephanMergener, KlausMoayyedi, PaulMurray, JosephAbbott (Speaker’s Bureau, Research Support); Janssen (Speaker’s Bureau); BMS (Consultant); Pfizer Inc (Consultant)Merck Canada (Speaker’s Bureau); Merck Global (Speaker’s Bureau); Abbott (Consultant, Speaker’s Bureau); Abbott International(Speaker’s Bureau); Shire (Consultant); Nestle (Speaker’s Bureau); Janssen (Consultant, Speaker’s Bureau); Centocor (Consultant)Cook Medical (Consultant); Ferring U.S. (Consultant); Ferring Canada (Research Support, Consultant)Janssen (Company Advisory Board, Research Support); Warner Chilcott (Speaker’s Bureau)Roche Diagnostics (Company Advisory Board); Otsuka Pharmacetuticals (Consultant); AstraZeneca (Consultant)Abbott (Speaker’s Bureau, Company Advisory Board); MSD (Speaker’s Bureau, Company Advisory Board); Warner Chilcott(Speaker’s Bureau, Company Advisory Board); Ferring Pharmaceuticals Inc (Speaker’s Bureau); Shire Pharmaceuticals Group Plc(Speaker’s Bureau, Company Advisory Board); Genentech Inc. (Company Advisory Board); Falk Pharma (Company Advisory Board)Engene (Research Support); Abbott (Company Advisory Board); Janssen (Company Advisory Board); CDRD (Research Support)Janssen (Speaker’s Bureau, Company Advisory Board); Shire Pharmaceuticals Group Plc (Consultant, Company Advisory Board);Abbott (Research Support, Company Advisory Board)Abbott (Speaker’s Bureau, Research Support, Company Advisory Board); Janssen (Speaker’s Bureau, Company Advisory Board);Shire Pharmaceuticals Group Plc (Research Support); Merck & Co (Speaker’s Bureau, Company Advisory Board)Janssen (Company Advisory Board); Abbott (Company Advisory Board); Baxter (Company Advisory Board); Warner Chilcott(Speaker’s Bureau)Janssen (Speaker’s Bureau, Company Advisory Board)BMS (Consultant, Research Support); Gilead Sciences Inc (Consultant, Research Support); Merck & Co (Consultant, ResearchSupport); Janssen (Consultant, Research Support); Roche (Consultant, Research Support); Abbott (Consultant, Research Support);Novartis Pharmaceuticals (Consultant); Vertex Pharmaceuticals (Consultant, Research Support)Exact Labs (Company Advisory Board); Given Imaging (Company Advisory Board); Roche (Company Advisory Board)Merck & Co (Company Advisory Board, Speaker’s Bureau, Research Support, Other); Abbott (Speaker’s Bureau, Company AdvisoryBoard, Other); Warner Chilcott (Speaker’s Bureau); Shire Pharmaceuticals Group Plc (Speaker’s Bureau, Research Support,Company Advisory Board, Other); Ferring Pharmaceuticals Inc (Speaker’s Bureau); Atlantic Healthcare (Company Advisory Board,Other); Vifor (Company Advisory Board); Takeda Pharmaceutical Company Ltd (Company Advisory Board); Abbott Hospira(Company Advisory Board)Takeda Pharmaceutical Company Ltd (Company Advisory Board); Janssen (Company Advisory Board, Speaker’s Bureau)Gilead Sciences Inc (Research Support, Company Advisory Board); Merck & Co (Company Advisory Board); Roche (ResearchSupport); BMS (Other); Vertex Pharmaceuticals (Research Support)Merck & Co (Speaker’s Bureau, Research Support); Vertex Pharmaceuticals (Speaker’s Bureau, Consultant); Boehringer Ingelheim(Research Support); Gilead Sciences Inc (Speaker’s Bureau, Consultant); BMS (Research Support); Roche (Consultant); Janssen(Consultant); Novartis Pharmaceuticals (Research Support)Shire Pharmaceuticals Group Plc (Company Advisory Board, Speaker’s Bureau); Takeda Pharmaceutical Company Ltd (CompanyAdvisory Board); Warner Chilcott (Speaker’s Bureau); Abbott (Company Advisory Board, Speaker’s Bureau); Aptalis (Speaker’sBureau); Ferring Pharmaceuticals Inc (Company Advisory Board, Speaker’s Bureau); Optimer Pharmaceuticals (Company AdvisoryBoard); Janssen (Company Advisory Board, Speaker’s Bureau)Abbott (Research Support); Gilead Sciences Inc (Research Support); Novartis Pharmaceuticals (Research Support)Abbott (Speaker’s Bureau); Cook Medical (Speaker’s Bureau)Takeda Pharmaceutical Company Ltd (Speaker’s Bureau); Janssen (Speaker’s Bureau)Hoffman‐LaRoche (Research Support)IntroMedic Co., Ltd. (Company Advisory Board); CapsoVision, LLC (Research Support); Innovative Anesthesia (Company AdvisoryBoard); Xlumena (Company Advisory Board); US Gastro LLC (Stockholder)AstraZeneca Pharmaceuticals LP (Company Advisory Board, Research Support); Shire Pharmaceuticals Group Plc (Speaker’s Bureau)Alba Therapeutics (Research Support); Alvine Inc (Consultant); ImmunosanT (Consultant); Ironwood (Consultant); Sonomoceuticalsinc (Consultant)

CDDW 2013 & the Annual CASL Winter MeetingFaculty Financial Interest DisclosureThe Canadian Association of Gastroenterology and the Canadian Association for the Study of the Liver must ensure balance, independence, objectivity, and scientific rigour inall educational and scientific activities. Accordingly, CDDW/CASL Winter Meeting faculty is expected to disclose to the audience any potential, apparent or actual interests orconnections that appear to influence their ability to act with integrity, objectivity, and independence on the assigned task. The intent of this disclosure summary is to providethe audience with information on the faculty interests/relationships that could influence interpretations, recommendations, and conclusions. For more information visit theCAG website at: http://www.cag‐acg.org/policiesThe following faculty have indicated that they do have relevant financial relationships of commercial interestMyers, RobertNguyen,GeoffreyPanaccione,RemoPaterson, WilliamPetrunia, DenisRamji, AlnoorRitchie, BruceRomagnuolo,JosephScarpignato,CarmeloShafran, StephenShanahan, FergusSherman, MorrisSteinhart, HillarySwain, MarkSwitzer, ConnieTurnbull,GeoffreyTurner, JustineTyrrell, LorneVan Assche, GertMerck & Co (Company Advisory Board); Roche (Company Advisory Board, Speaker’s Bureau); Vertex Pharmaceuticals (CompanyAdvisory Board, Speaker’s Bureau); Johnson & Johnson (Janssen) (Company Advisory Board); Boehringer Ingelheim (CompanyAdvisory Board); GE Healthcare (Company Advisory Board); Norgine Ltd. (Company Advisory Board)Johnson & Johnson (Janssen) (Consultant, Speaker’s Bureau); Abbott (Consultant); Aptalis (Speaker’s Bureau)Abbott (Consultant, Speaker’s Bureau, Research Support, Company Advisory Board); BMS (Consultant, Company Advisory Board);Baxter Healthcare Corporation (Consultant, Company Advisory Board); Biogen/IDEC (Consultant, Company Advisory Board);Celgene Corporation (Company Advisory Board); Eisai Co. Ltd (Consultant); Elan Pharmaceuticals, Inc. (Consultant, CompanyAdvisory Board); Falk Foundation (Speaker’s Bureau); Human Genome Sciences, Inc. (Consultant, Company Advisory Board);Janssen (Consultant, Company Advisory Board, Research Support); Johnson & Johnson (Janssen) (Company Advisory Board,Research Support, Speaker’s Bureau); Nestle Nutrition (Consultant, Speaker’s Bureau, Research Support); Pfizer Inc (Consultant,Company Advisory Board, Research Support); Salix Pharmaceuticals, Inc. (Consultant; Company Advisory Board); Santarus, Inc.(Company Advisory Board, Research Support); Takeda Pharmaceutical Company Ltd (Consultant, Company Advisory Board)Janssen (Company Advisory Board, Speaker’s Bureau)Takeda (Speaker’s Bureau, Company Advisory Board); Janssen (Speaker’s Bureau); Shire (Company Advisory Board); Pendopharm(Company Advisory Board); Abbott (Research Support)Boehringer Ingelheim (Company Advisory Board, Research Support); Gilead Sciences Inc (Speaker’s Bureau, Company AdvisoryBoard, Research Support); Merck & Co (Speaker’s Bureau, Company Advisory Board, Research Support); Roche (Speaker’sBureau, Company Advisory Board, Research Support); Vertex Pharmaceuticals (Speaker’s Bureau, Research Support, CompanyAdvisory Board); BMS (Research Support); Janssen (Company Advisory Board)CSL‐Behring (Research Support, Consultant); Baxer (Research Support, Consultant); Pfizer (Research Support, Consultant); NovoNordisk (Research Support, Consultant); Bayer (Consultant); Covidien (Consultant)Cook Medical (Speaker’s Bureau)AstraZeneca (Speaker’s Bureau); Pfizer (Speaker’s Bureau, Research Support); Janssen (Speaker’s Bureau); Shire (Speaker’s Bureau);Chiesi Group (Speaker’s Bureau); Boehringer‐Ingelheim (Consultant); Alfa‐Wassermann (Consultant, Research Support); Warner‐Chilcott (Consultant); Reckitt‐Benkiser (Consultant, Speaker’s Bureau)Abbott (Consultant, Company Advisory Board, Research Support); BMS (Research Support, Company Advisory Board); BoehringerIngelheim (Research Support, Company Advisory Board); Gilead Sciences Inc (Research Support, Company Advisory Board);Merck & Co (Research Support, Company Advisory Board); Pfizer Inc (Company Advisory Board); Roche (Research Support,Company Advisory Board); Janssen (Company Advisory Board); Vertex Pharmaceuticals (Research Support, Company AdvisoryBoard)Alimentary Health (Stockholder); Trion pharmaceuticals (Company Advisory Board); GlaxoSmithKline (Research Support)Merck & Co (Speaker’s Bureau, Consultant); Vertex Pharmaceuticals (Speaker’s Bureau, Consultant); Janssen (Consultant);Boehringer Ingelheim (Consultant); Gilead Sciences Inc (Consultant); BMS (Consultant)Janssen (Company Advisory Board, Speaker’s Bureau); Abbott (Company Advisory Board, Research Support); Shire PharmaceuticalsGroup Plc (Company Advisory Board, Speaker’s Bureau); Warner Chilcott (Company Advisory Board, Speaker’s Bureau); FerringPharmaceuticals Inc (Speaker’s Bureau); Aptalis (Speaker’s Bureau); GlaxoSmithKline (Research Support); Amgen (ResearchSupport); Pfizer Inc (Research Support); Millennium Research Group (Research Support); Pendopharm (Consultant)Idenix Pharmaceuticals (Other); Gilead Sciences Inc (Company Advisory Board, Other); GlycoReg Immune (Consultant); VertexPharmaceuticals (Company Advisory Board); Boehringer Ingelheim (Company Advisory Board)Ferring Pharmaceuticals Inc (Other); Takeda Pharmaceutical Company Ltd (Speaker’s Bureau)Janssen Inc. (Speaker’s Bureau, Consultant)Fresenius Kabi (Research Support)KMT Hepatech (Employee, Stockholder); Merck & Co (Research Support); GlaxoSmithKline (Research Support); Bristol‐Myers Squibb(Research Support)Abbott (Speaker’s Bureau, Research Support); MSD (Speaker’s Bureau, Research Support); Novartis Pharmaceuticals (Consultant);Ferring Pharmaceuticals Inc (Company Advisory Board); BMS (Company Advisory Board); Zealand Pharma (Company AdvisoryBoard)

CDDW 2013 & the Annual CASL Winter MeetingFaculty Financial Interest DisclosureThe Canadian Association of Gastroenterology and the Canadian Association for the Study of the Liver must ensure balance, independence, objectivity, and scientific rigour inall educational and scientific activities. Accordingly, CDDW/CASL Winter Meeting faculty is expected to disclose to the audience any potential, apparent or actual interests orconnections that appear to influence their ability to act with integrity, objectivity, and independence on the assigned task. The intent of this disclosure summary is to providethe audience with information on the faculty interests/relationships that could influence interpretations, recommendations, and conclusions. For more information visit theCAG website at: http://www.cag‐acg.org/policiesThe following faculty have indicated that they do have relevant financial relationships of commercial interestVerdu, ElenaWales, PaulWaterhouse,ChristopherWong, ClarenceWong, FlorenceWong, PhilWong, KarenYoshida, EricNestle Nutrition (Research Support); Bioline Rx (Research Support)Fresenius Kabi (Research Support)Johnson & Johnson (Janssen) (Company Advisory Board)Takeda Pharmaceutical Company Ltd (Speaker’s Bureau, Company Advisory Board); Nycomed (Speaker’s Bureau, Company AdvisoryBoard); Pendopharm Inc. (Company Advisory Board, Speaker’s Bureau); Ferring Pharmaceuticals Inc (Consultant); Abbott(Speaker’s Bureau); AstraZeneca Pharmaceuticals LP (Speaker’s Bureau); BARRX Medical, Inc. (Research Support); AMSURG(Research Support)Gore (Research Support)Merck (Company Advisory Board, Speaker’s Bureau); Gilead (Company Advisory Board, Speaker’s Bureau); Roche (CompanyAdvisory Board); Vertex (Company Advisory Board)Janssen (Company Advisory Board)Vertex Inc (Research Support, Other); Merck Inc (Research Support, Other); Norvartis Inc (Research Support); Hoffman LaRoche Ince(Research Support, Other); Gilead Sciences Inc (Research Support, Other); Pfizer Inc (Research Support); Boeringher Ingleheim(Research Support); Astellas Inc (Other)The following faculty have indicated that they do not have relevant financial relationships of commercial interestAdams, Paul Altier, Christophe Aspinal, Alex Aubertin, GudrunAvitzur, Yaron Bailey, Robert Bain, Vince Beyak, MichaelBoisvert, François‐Michel Borgaonkar, Mark Boudreau, François Bridges, RonaldButzner, J Decker Carrier, Julie Chapkin, Robert Czaja, AlbertDaniels, Sandra Duerksen, Donald Eksteen, Bertus Farmer, UlanaGibson, Deanna Gregor, Jamie Gupta, Milli Gupta, MilliHeitman, Steven Jabri, Bana Jackson, Timothy Jayakumar, SaumyaJones, Nicola Kamath, Binita Kao, Dina Karpen, SaulKarvellas, Dean Kassam, Zain Khan, Waliul Khan, KhurramKo, Hin Hin Lalor, Eoin Lam, Eric Leddin, DesmondLilly, Les Lomax, Alan MacIntosh, Donald MacNaughton, WallaceMarcon, Peggy May, Catherine McCafferty, Donna‐Marie Meddings, JonMieli‐Vergani, Giorgina Montano‐Loza, Aldo Morinville, Veronique Morris, DonMuise, Aleixo Nahirniak, Susan Nash, Carla Peltekian, KevorkPeltekian, Kevork Peretz, David Perreault, Nathalie Rabeneck, LindaRabeneck, Linda Raman, Maitreyi Relman, David Renner, EberhardRobbins, Sarah Rose, Christopher Rossos, Peter Rostom, AlaaSadowski, Dan Saleh, Maya Sandha, Gurpal Scudamore, CharlesSebastiani, Giada Selvarajah, Vijay Sewitch, Maida Sharkey, KeithSly, Laura Stappenbeck, Thaddeus Support, Meetings Surette, MichaelTam, Edward Tandon, Puneeta Telford, Jennifer Teshima, ChristopherTétreault, Marie‐Pier Vallance, Bruce Vanner, Stephen Vergani, DiegoWaschke, Kevin Williams, Geoff Yap, Jason Zaph, ColbyZaph, Colby Zeman, Marilyn Zwingmann, ClaudiaThe following faculty did not complete the financial interest disclosure formScully, LindaWhittaker, Scott